Cargando…

A narrative review: CXC chemokines influence immune surveillance in obesity and obesity-related diseases: Type 2 diabetes and nonalcoholic fatty liver disease

Adipose tissue develops lipids, aberrant adipokines, chemokines, and pro-inflammatory cytokines as a consequence of the low-grade systemic inflammation that characterizes obesity. This low-grade systemic inflammation can lead to insulin resistance (IR) and metabolic complications, such as type 2 dia...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ullah, Amin, Ud Din, Ahmad, Ding, Wen, Shi, Zheng, Pervaz, Sadaf, Shen, Bairong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10063956/ https://www.ncbi.nlm.nih.gov/pubmed/37000372 http://dx.doi.org/10.1007/s11154-023-09800-w

Ejemplares similares

Pathophysiological impact of CXC and CX3CL1 chemokines in preeclampsia and gestational diabetes mellitus
por: Ullah, Amin, et al.
Publicado: (2023)

Roles of Chemokines and Chemokine Receptors in Obesity-Associated Insulin Resistance and Nonalcoholic Fatty Liver Disease
por: Xu, Liang, et al.
Publicado: (2015)

The Role of CXC Chemokines in Cardiovascular Diseases
por: Lu, Xiyi, et al.
Publicado: (2022)

The Effect of Hypoxia on the Expression of CXC Chemokines and CXC Chemokine Receptors—A Review of Literature
por: Korbecki, Jan, et al.
Publicado: (2021)

CXC Chemokines in the Pathogenesis of Pulmonary Disease and Pharmacological Relevance
por: Komolafe, Kayode, et al.
Publicado: (2022)

The Role of CXC Chemokines in Cancer Progression
por: Wu, Tiantian, et al.
Publicado: (2022)

Comparison between obese and non-obese nonalcoholic fatty liver disease
por: Chan, Wah-Kheong
Publicado: (2023)

Obesity and nonalcoholic fatty liver disease: current perspectives
por: Sarwar, Raiya, et al.
Publicado: (2018)

Gut Microbiota and Clinical Disease: Obesity and Nonalcoholic Fatty Liver Disease
por: Park, Ji Sook, et al.
Publicado: (2013)

Identification of the Receptor and Cellular Ortholog of the Marek's Disease Virus (MDV) CXC Chemokine
por: Haertle, Sonja, et al.
Publicado: (2017)

Nonalcoholic fatty liver disease in obese and nonobese pediatric patients
por: Kim, Eun Jeong, et al.
Publicado: (2019)

CXC and CC Chemokines as Angiogenic Modulators in Nonhaematological Tumors
por: Santoni, Matteo, et al.
Publicado: (2014)

Selected CC and CXC chemokines in children with atopic asthma
por: Machura, Edyta, et al.
Publicado: (2016)

Prognostic Biomarkers and Immunotherapeutic Targets Among CXC Chemokines in Pancreatic Adenocarcinoma
por: Huang, Jiacheng, et al.
Publicado: (2021)

The Involvement of CXC Motif Chemokine Ligand 10 (CXCL10) and Its Related Chemokines in the Pathogenesis of Coronary Artery Disease and in the COVID-19 Vaccination: A Narrative Review
por: Karimabad, Mojgan Noroozi, et al.
Publicado: (2021)

Comparison of Obesity-Related Indicators for Nonalcoholic Fatty Liver Disease Diagnosed by Transient Elastography
por: Tian, Xinyi, et al.
Publicado: (2023)

Nonalcoholic fatty liver disease: an emerging threat to obese and diabetic individuals
por: Masuoka, Howard C, et al.
Publicado: (2013)

Surgical treatment of nonalcoholic fatty liver disease in severely obese patients
por: Vander Naalt, Steven J, et al.
Publicado: (2014)

Obesity, Nonalcoholic Fatty Liver Disease and Adipocytokines Network in Promotion of Cancer
por: Divella, Rosa, et al.
Publicado: (2019)

Management of Obesity and Nonalcoholic Fatty Liver Disease: A Literature Review
por: Hashem, Anas, et al.
Publicado: (2021)

Obesity Modifies the Performance of Fibrosis Biomarkers in Nonalcoholic Fatty Liver Disease
por: Qadri, Sami, et al.
Publicado: (2021)

Crosstalk between dietary patterns, obesity and nonalcoholic fatty liver disease
por: Ristic-Medic, Danijela, et al.
Publicado: (2022)

Sarcopenic Obesity, the Possible Culprit for Nonalcoholic Fatty Liver Disease or Fibrosis
por: Kang, Seong Hee, et al.
Publicado: (2023)

Expression of STING in Women with Morbid Obesity and Nonalcoholic Fatty Liver Disease
por: Bertran, Laia, et al.
Publicado: (2023)

The CXC-Chemokine CXCL4 Interacts with Integrins Implicated in Angiogenesis
por: Aidoudi, Sallouha, et al.
Publicado: (2008)

ELR+ CXC chemokine expression in benign and malignant colorectal conditions
por: Rubie, Claudia, et al.
Publicado: (2008)

CXC-Type Chemokines Promote Myofibroblast Phenoconversion and Prostatic Fibrosis
por: Gharaee-Kermani, Mehrnaz, et al.
Publicado: (2012)

CXC Chemokine/Receptor Axis Profile and Metastasis in Prostate Cancer
por: Nagaya, Naoya, et al.
Publicado: (2020)

Mechanism of Cxc Chemokine Ligand 5 (CXCL5)/Cxc Chemokine Receptor 2 (CXCR2) Bio-Axis in Mice with Acute Respiratory Distress Syndrome
por: Wang, Chang-yong, et al.
Publicado: (2019)

Cloning and bioactivity analysis of a CXC ligand in black seabream Acanthopagrus schlegeli: the evolutionary clues of ELR(+)CXC chemokines
por: Zhonghua, Cai, et al.
Publicado: (2008)

Comparison of Clinical Characteristics Between Obese and Non-Obese Patients with Nonalcoholic Fatty Liver Disease (NAFLD)
por: Li, Yifang, et al.
Publicado: (2021)

Comparison of cardiometabolic risk factors between obese and non-obese patients with nonalcoholic fatty liver disease
por: Yari, Zahra, et al.
Publicado: (2023)

CC and CXC chemokine levels in children with meningococcal sepsis accurately predict mortality and disease severity
por: Vermont, Clementien L, et al.
Publicado: (2006)

Surveillance of Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease
por: Sumida, Yoshio, et al.
Publicado: (2020)

Antioxidant vitamins in the context of nonalcoholic fatty liver disease in obese children and adolescents
por: Ued, Fábio da Veiga, et al.
Publicado: (2013)

The Potential Role of Iron and Copper in Pediatric Obesity and Nonalcoholic Fatty Liver Disease
por: Feldman, Alexandra, et al.
Publicado: (2015)

Visceral Obesity Predicts Significant Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
por: Yu, Su Jong, et al.
Publicado: (2015)

The Role of Intestinal Bacteria Overgrowth in Obesity-Related Nonalcoholic Fatty Liver Disease
por: Ferolla, Silvia M., et al.
Publicado: (2014)

The Impact of Nonalcoholic Fatty Liver Disease on Renal Function in Children with Overweight/Obesity
por: Pacifico, Lucia, et al.
Publicado: (2016)

Increased serum concentration of ceramides in obese children with nonalcoholic fatty liver disease
por: Wasilewska, Natalia, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_6cn6i3bdpkiuv74feg8log9osm